HAMLET B — Hamlet BioPharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Hamlet BioPharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	7.47	39.6	18.4	23.1	10.8
Net Total Receivables	0.496	0.847	0.49	3.73	1.56
Prepaid Expenses
Total Current Assets	12.7	41.7	19	27.3	12.8
Net Property, Plant And Equipment	0.009	0	0	0.574	0.217
Net Intangible Assets
Total Assets	12.7	41.7	28.5	68.6	43.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.99	3.72	2.55	4.11	7.27
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.99	3.72	7.55	4.11	7.27
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.75	38	20.9	64.5	36.3
Total Liabilities & Shareholders' Equity	12.7	41.7	28.5	68.6	43.6
Total Common Shares Outstanding